Ignite Creation Date:
2025-12-24 @ 10:23 PM
Ignite Modification Date:
2025-12-24 @ 10:23 PM
Study NCT ID:
NCT01232335
Status:
COMPLETED
Last Update Posted:
2013-05-29
First Post:
2010-10-31
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Symbicort Turbuhaler 30/60 Specific Clinical Experience Investigation
Sponsor:
AstraZeneca
Organization:
Study Overview
Official Title:
Symbicort Turbuhaler 30/60 Specific Clinical Experience Investigation for Long-term Use
Status:
COMPLETED
Status Verified Date:
2013-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ENSURE
Brief Summary:
The purpose of this study is to confirm the safety profile for long term treatment and maximize doses and the control status on bronchial asthma in daily clinical usage
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: